These observations strongly suggest a pathologic role for CTGF in diabetic nephropathy and, as well, a recent report [20] provides putative mechanistic insights into the manner in CTGF may affect matrix biology in the setting of hyperglycemia and/or diabetes mellitus. This evidence concerns the gene CCN2 and diabetic kidney disease.